New insights into how tumors metabolically adapt to their environment may lead to better cancer therapies: The NAD+ biosynthetic pathway drives immunosuppression in high-grade serous ovarian cancer

A research team has discovered novel metabolic mechanisms that contribute to how ovarian cancer escapes from immune attack, and how combination therapies can exploit these pathways to improve ovarian cancer treatment.

Leave a Comment